Bringing the fundamentals into focus…
Back to Lexicon Pharmaceuticals, Inc.
How Lexicon Pharmaceuticals, Inc. stacks up
LXRX · against 436 other Healthcare companies of similar size
Growth
81/ 100
Near the top of its peers.
Ranked #64 of 437 · scores higher than 85% of peers
Bars: peers in each 10-point band of the growth score36 peers with a growth score of 80–89, including LXRX · Click a bar to see the companies
Why growth scores 81?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth, which is stronger than most Healthcare peers.
- slower revenue growth over the last year: weaker than 93% of peers. Revenue growth: -29.0% vs peer median 6.1%
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over three years: stronger than 99% of peers. 3-year revenue growth: 367.1% vs peer median 5.8%
Metric by metric
Position: dot = LXRX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | LXRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 450 reported | -29.0% | 3.3% | 8% | 33% | |
| Earnings per share growthHigher is better · 230 reported | Not reported | 3.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 429 reported | 367.1% | 4.2% | 99% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around LXRX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 2 | 609M USD | 99 | 91 | |
| 62 | 8.1B HKD (≈$1.0B) | 82 | 70 | |
| 62 | 7.1B CNY (≈$998M) | 82 | 56 | |
| 64 | 7.1B CNY (≈$988M) | 81 | 46 | |
| 64 | 578M USD | 81 | 73 | |
| 64 | 650M USD | 81 | 48 | |
| 64 | 423M USD | 81 | 29 | |
| 64 | 1.1B USD | 81 | 50 | |
| 69 | 5.9B HKD (≈$760M) | 80 | 59 | |
| 69 | 1.2B USD | 80 | 67 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score